Also known as: weed for period pain · marijuana for dysmenorrhea · cannabis for PMS

Cannabis and Menstrual Cramps

What the evidence actually says about using cannabis for dysmenorrhea, PMS pain, and endometriosis-related cramping.

Sourced and fact-checked
12 cited sources
Published 3 months ago
How this page was made
↯ The honest take

Period cramps are one of the oldest claimed uses for cannabis, and survey data shows lots of people who try it report relief. But 'lots of people say it helps' is not the same as 'we have good clinical trials.' As of 2024 there are essentially no randomized controlled trials of cannabis specifically for menstrual pain. The honest answer is: plausible mechanism, strong anecdote, weak clinical evidence, and real risks worth knowing about — especially with vaginal suppositories, which are mostly marketing.

Not medical advice

This article is educational, not medical advice. Menstrual pain can have many causes, including endometriosis, adenomyosis, fibroids, pelvic inflammatory disease, and ovarian cysts. Severe or worsening period pain deserves a real workup by a clinician, not self-treatment. Talk to a doctor before substituting cannabis for prescribed treatment.

Plain-language summary

Menstrual cramps (dysmenorrhea) are caused mostly by prostaglandins — signaling molecules that make the uterus contract and constrict blood flow [1]. Standard first-line treatments (ibuprofen, naproxen, hormonal contraceptives) work by blocking prostaglandin production or suppressing ovulation [1][2].

Cannabis works through a completely different system: the endocannabinoid system, which is present in uterine tissue and appears to modulate pain, inflammation, and smooth-muscle contraction [3]. That's the theoretical basis for why it might help.

The practical reality: people have used cannabis for period pain for centuries Anecdote, modern surveys show many users report meaningful relief Weak / limited [4][5], but rigorous randomized controlled trials in humans with menstrual pain are essentially absent.

What probably works

Honestly, nothing in this category yet meets a 'probably works' bar by clinical-trial standards. For menstrual pain specifically, no cannabis intervention has been shown in well-designed RCTs to outperform placebo or standard care.

The closest we get:

What might work

What doesn't work, or has weak/no evidence

What we don't know

Comparison with standard treatments

NSAIDs (ibuprofen, naproxen, mefenamic acid) remain first-line and are genuinely effective for most primary dysmenorrhea, with number-needed-to-treat around 2–4 Strong evidence [1][2]. They directly block the prostaglandin pathway that causes cramps. They're cheap, available, and well-studied. Side effects (GI upset, kidney strain with chronic use) are real but manageable.

Combined hormonal contraceptives reduce menstrual pain in most users by suppressing ovulation and thinning the endometrium Strong evidence [2].

Heat (heating pads, hot water bottles) has small but real RCT evidence and essentially zero downside Strong evidence [9].

Cannabis has not been compared head-to-head with any of these in a controlled trial. Survey data suggests users perceive it as comparable to or better than OTC analgesics Weak / limited [4], but that's not the same as showing it. A reasonable framing: cannabis is a possible adjunct, not a demonstrated replacement, for people whose pain isn't controlled by NSAIDs and hormonal options, or who can't tolerate them.

Risks and side effects

Practical bottom line

If NSAIDs and a heating pad handle your cramps, you don't need cannabis for this. If they don't, and you're in a legal jurisdiction and not pregnant or trying to be, cannabis is a reasonable thing to try with eyes open — knowing the evidence base is mostly survey data and personal experience, not rigorous trials. Start low, oral or inhaled rather than expensive suppositories, and don't let it replace a proper workup if your pain is severe, worsening, or new.

Sources

  1. Peer-reviewed Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Human Reproduction Update. 2015;21(6):762-778.
  2. Peer-reviewed Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database of Systematic Reviews. 2015;(7):CD001751.
  3. Peer-reviewed Walker OS, Holloway AC, Raha S. The role of the endocannabinoid system in female reproductive tissues. Journal of Ovarian Research. 2019;12:3.
  4. Peer-reviewed Sinclair J, Collett L, Abbott J, Pate DW, Sarris J, Armour M. Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. PLoS ONE. 2021;16(10):e0258940.
  5. Peer-reviewed Armour M, Sinclair J, Chalmers KJ, Smith CA. Self-management strategies amongst Australian women with endometriosis: a national online survey. BMC Complementary and Alternative Medicine. 2019;19:17.
  6. Peer-reviewed National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
  7. Peer-reviewed Brown JD, Winterstein AG. Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. Journal of Clinical Medicine. 2019;8(7):989.
  8. Peer-reviewed Jukic AMZ, Weinberg CR, Baird DD, Wilcox AJ. Lifestyle and reproductive factors associated with follicular phase length. Journal of Women's Health. 2007;16(9):1340-1347.
  9. Peer-reviewed Akin MD, Weingand KW, Hengehold DA, et al. Continuous low-level topical heat in the treatment of dysmenorrhea. Obstetrics & Gynecology. 2001;97(3):343-349.
  10. Peer-reviewed Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review. Journal of Medical Toxicology. 2017;13(1):71-87.
  11. Peer-reviewed Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235-1242.
  12. Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics & Gynecology. 2017;130(4):e205-e209.

How this page was made

Generation history

Feb 11, 2026
Fact-check pass — raised 2 flags
Feb 10, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.